PDZ‐binding kinase inhibitor OTS514 suppresses the proliferation of oral squamous carcinoma cells
E2F
E2F1
DOI:
10.1111/odi.14533
Publication Date:
2023-02-17T10:58:44Z
AUTHORS (16)
ABSTRACT
PDZ-binding kinase (PBK) has been reported as a poor prognostic factor and is promising molecular target for anticancer therapeutics. Here, we aimed to investigate the effect of specific PBK inhibitor OTS514 on survival OSCC cells.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (44)
CITATIONS (0)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....